ARTICLE | Financial News

Idera raises $50M follow-on

October 27, 2017 7:03 PM UTC

On Oct. 26, Idera Pharmaceuticals Inc. (NASDAQ:IDRA) raised $50 million through the sale of 33.3 million shares at $1.50 in a follow-on underwritten by JPMorgan, Goldman Sachs, Barclays and H.C. Wainwright. The price is a 31% discount to Idera's close of $2.18 on Oct. 24, when it proposed the offering after market hours...

BCIQ Company Profiles

Aceragen Inc.

BCIQ Target Profiles

Toll-like receptor 9 (TLR9)